Liquid Biopsies: A Less Invasive Alternative for Cancer Diagnosis

When it comes to diagnosing cancer, a tissue biopsy is the standard test. However, a less invasive alternative called a liquid biopsy is gaining attention for its potential to provide a diagnosis when a traditional biopsy may not be possible or practical.

What is a Liquid Biopsy?

A liquid biopsy uses a person's blood to look for signs of cancer. The test aims to detect circulating tumor cells or mutated DNA that a tumor has shed into the bloodstream. By analyzing these components, doctors can potentially:

• Predict and monitor responses to cancer treatments

• Detect cancer early, before it has had a chance to spread

Advantages of Liquid Biopsies

Compared to traditional tissue biopsies, liquid biopsies offer several advantages:

1. Less invasive and painful, as they only require a blood sample

2. Can find cancer-specific DNA in more than 85% of patients with advanced cancers

3. Can help identify cancer that tissue biopsies may miss

4. Can determine when cancer treatments are no longer effective by detecting genetic mutations that cause resistance to therapy

The Future Role of Liquid Biopsies

While liquid biopsies show promise, their impact on overall cancer survival is not yet known. Currently, liquid biopsies are used alongside tissue biopsies to confirm a diagnosis and guide treatment. This two-sided approach is necessary because, although liquid biopsies have a good track record for accuracy, they can still miss cancers in some people or suggest cancer is present when it isn't.

As research continues, liquid biopsies may play an increasingly important role in cancer care. Their less invasive nature and ability to detect cancer early could ultimately lead to better outcomes for patients.

Additional Resources:

• Liquid Biopsy: Using DNA in Blood to Detect, Track, and Treat Cancer - National Cancer Institute

• Liquid biopsy - Mayo Clinic

• Liquid Biopsies: Past, Present, and Future - American Cancer Society